News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$CBIH Price is cheap and holding up! Potential Merger was announced earlier, when that happens CBIH will be flying up real high! https://www.cbih.net/
BUSINESS DESCRIPTION
The company is dedicated to providing services in all therapeutic areas of clinical research through one of our products: Alpha Research Institute, LLC. a Houston-based Research Unit that offers phase I to phase IV Clinical Research Studies. The Company also operates an international learning platform that provides knowledge about cannabinoids' medical benefits: Pharmacology University. We have been researching medical cannabis uses for more than 15 years, as a result, we have published ebooks, audiobooks, videos, and magazines. Cannabis Bioscience International Holdings will unite both experiences, clinical studies, and knowledge about cannabinoids.
It's holding up!
CBIH I've seen this climb, when it climbs it'll go high!
Please be patient. The last couple of days we did nothing but to water the plant, we are under a couple of non circumvent / non disclosure agreements, thank you for your interest. pic.twitter.com/I409GJKzTx
— CBIH (@CBIHstock) March 14, 2024
Bought 11's here today!
$CBIH Nice day! Merger and other excellent news are incoming!
$CBIH
Blessed to be part of the greatest medical cannabis company on the OTCMKTS $CBIH - synonym of the future of cannabis medicine https://t.co/Wr3n9RlXD3
— CBIH (@CBIHstock) March 10, 2024
CBIH @CBIHstock
Houston, Texas--(Newsfile Corp. - March 6, 2024) - Cannabis Bioscience International Holdings, Inc. (OTC Pink: $CBIH) announces that Dante Picazo, its chief executive officer, is contributing one billion shares of his common #stock to the Company. These #shares will be retired and have the status of authorized and unissued shares. As a result of this contribution, the number of the Company's outstanding shares has been reduced to approximately 9.4 billion. Since current management assumed control of the Company in 2019, its members have contributed 5.5 billion shares to the Company for no or nominal consideration. The shares have a #market price of approximately $5 million, valued at the closing price of $0.0009 on March 5, 2024. The Company believes that Mr. Picazo's contribution will increase #shareholdervalue
https://ca.finance.yahoo.com/news/cbih-announces-retirement-one-billion-130000159.html
#retirementofshares #stockstowatch #aistocks #MarketNews
5:14 AM · Mar 6, 2024
$CBIH Progress in the making: Possible Merger!
Excellent week! CBIH is talking to a couple of great medical companies about a possible merger.
#CBIH #stock #medicine #medicalcannabis #biotechnology
Brian Cuban Joins Cannabis Bioscience International Holdings as an Advisory Board Member.
https://www.otcmarkets.com/stock/CBIH/news/Brian-Cuban-Joins-Cannabis-Bioscience-International-Holdings-as-an-Advisory-Board-Member?id=431463
@CBIHstock Feb 20
$CBIH Cannabis Bioscience International Holdings, Inc. Announces Engagement of Bull in Advantage as its Investor Relations Firm https://wsj.com/articles/cannabis-bioscience-international-holdings-inc-announces-engagement-of-bull-in-advantage-as-its-investor-relations-firm-57129896 via
@WSJ #Cannabisstocks #Pennystocks #Pharmastocks #Stockfocuslist #Stockstowatch #Pharmaceutical #Biotechnology…
Show more
CBIH Profile. https://www.otcmarkets.com/stock/CBIH/profile
https://www.cbih.net/_files/ugd/172074_675abb627ad4498285cdfa4186ec23e4.pdf
$CBIH https://t.co/Wr3n9RlXD3 pic.twitter.com/L5iF4ngioh
— CBIH (@CBIHstock) March 2, 2024
Yeah, let's do it! CBIH has been a good runner in the past!
$CBIH Brian Cuban Joins Cannabis Bioscience International Holdings as an Advisory Board Member. Newsfile Corp.
Houston, Texas--(Newsfile Corp. - February 26, 2024) - Cannabis Bioscience International Holdings (OTC Pink: CBIH) is excited to announce that Brian Cuban has been elected by our firm as an Advisory Board Member. Mr. Cuban will bring decades of experience in legal and corporate leadership, and a long track record of coaching diverse professionals around the world.
merger tweets per company hmm https://twitter.com/CBIHstock
Is the S1 filing for an IPO to up list to Nasdaq/ NY exchange? Or is it for a Financing/IPO which is also done with a S1 filing?
Is the S1 filing for an IPO to up list to Nasdaq/ NY exchange? Or is it for a Financing/IPO which is also done with a S1 filing?
$CBIH https://www.cbih.net/
$CBIH Cannabis Bioscience International Holdings (CBIH) Unveils Its Rebranding Through Its New and Innovative Website
https://www.globenewswire.com/news-release/2023/09/11/2740912/0/en/Cannabis-Bioscience-International-Holdings-CBIH-Unveils-Its-Rebranding-Through-Its-New-and-Innovative-Website.html
HOUSTON, Texas, Sept. 11, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Cannabis Bioscience International Holdings (trading on the OTC Markets under the ticker symbol CBIH), a medical research company that specializes in clinical trials and cannabinoids education, proudly announces the launch of its new website as a part of its bold rebranding strategy.
The new web page better represents the company’s values and vision, predominantly in the areas of research and production of cannabis as medicine. In particular with its purpose of providing patients with healing alternatives when struggling with chronic conditions, inflammatory diseases, and side effects of opioids and other traditional treatments. Additionally, the new website is expected to be an important step forward for the relationship of the company with its Investors and those interested in being involved. The rebranding efforts at CBIH encompass several exciting elements, including: a scientific design concept, sources for qualified investors, a new corporate email, and clear information about who the company is, what is it doing, and what the future plans are.
The new CBIH website link is www.cbih.net. “This new website undoubtedly represents our scientific spirit. We invite qualified investors to review the presentation of the projects that the company expects to develop in the next 5 years, including the selection of some of the product formulations that the company owns. We also make public that investors and interested parties may contact the company directly through the new e-mail ir@cbih.net,” mentioned Henry Levinski, VP/Treasurer of CBIH.
By defining the brand identity, the company strives to position itself as the market leader for cannabinoid data clinical studies and a harborage for those patients that traditional medicine has forgotten.
